NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

Glioma is one of the most deadly types of brain cancer. As it is highly invasive, the prognosis for glioma patients remains dismal, with median survival rarely exceeding 16 months. Thus, developing a new prognostic biomarker for glioma and investigating its molecular mechanisms is necessary for the...

Full description

Bibliographic Details
Main Authors: Guangrong Zheng, Tao Han, Xiaomu Hu, Zhou Yang, Jin Wang, Zhenyi Wen, Hengyu Li, Hongjin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.770628/full